Participate in Research

Browse Clinical Trials
Study for brain hemorrhage patients
Protocol: SITE00000015
Full Title
STATINS USE IN INRACEREBRAL HEMORRHAGE PATIENTS (SATURN)
Description
This study enrolls adults who have had a brain hemorrhage within the last 7 days. The purpose of the study is to learn whether it is better to keep taking or stop taking the medication statin after having a brain bleed.

You will be in this study for about 2 years. You will be contacted by phone, mail, or video call during that time to learn more about how you have been doing. During the study you will be randomly selected to either keep taking your statin medication or to stop taking it. Study takes place at Buffalo General Medical Center/Gates Vascular Institute.
Compensation: No
Eligibility
Adults ages 50+.
Have had bleeding in the brain (brain hemorrhage) within the last 7 days.
Were taking a statin drug.
People who may be eligible for this study will be contacted by study staff directly. Eligible participants will be inpatients of Buffalo General/Gates Vascular Institute.
Age Group: Adults
ClinicalTrials.gov: Open Study

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Thank you for your interest. This study has restricted recruiting for participants and is not accepting inquiries at this time. If you are interested in learning more about studies at UB, you can sign up for the Buffalo Research Registry.
Study teams can login to review submissions
Study Team Login